# Buprenorphine and Naloxone

NDC: 3215-6523
Generic name: buprenorphine and naloxone
Labeler / Manufacturer: Aveva Drug Delivery Systems Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: FILM
Routes: BUCCAL, SUBLINGUAL
Marketing started: 20230829

FDA application: ANDA212756

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"3215-6523"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=3215-6523
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb112448-49a1-4209-bcdb-7cfae6501f51